Systemic iron sequestration restricts the intratumoral CD8+ T cell landscape in pancreas cancer

Elevated serum hepcidin linked to reduced intratumoral CD8+ T cells and poorer survival in pancreas cancer patients, highlighting iron sequestration's impact on tumor immunity.

• Why it matters: Understanding how systemic iron regulation influences immune responses within tumors is crucial, as iron dysregulation is common in cancer but its effects on immunity remain unclear.
• What they did: The study analyzed patient data and used a hepcidin mimetic in mice to mimic iron sequestration, revealing that iron restriction impairs high avidity CD8+ T cells through mitochondrial dysfunction.
• The result: Findings suggest targeting systemic iron dysregulation could boost anti-tumor CD8+ T cell activity, offering a new therapeutic avenue for improving immune responses in pancreas cancer.